Skip to content
Corporate Social Responsibility
Management Team Board of Directors Corporate Social Responsibility Ethics Advisory Board

Corporate Social Responsibility

Genomics for good

We are driven by the power of genomics to positively impact the world and shape a more sustainable and equitable future for all.

Genomics for good

We are driven by the power of genomics to positively impact the world and shape a more sustainable and equitable future for all.

By embedding our CSR strategy into our business, we are driving positive stakeholder impact and long-term shareholder value

Innovating at the intersection of biology, technology, and health, Illumina is advancing genomics for good to create a healthier, more sustainable, and more equitable future for all. Our CSR strategy promotes the sustainable stewardship of our business by focusing on four key pillars:

Accelerate access to genomics
Accelerate access to genomics
integrating genomics and environmental sustainability
Integrate sustainability
Illumina corporate citizenship
Nurture our people and communities
how Illumina operates responsibly
Operate responsibly
progress Illumina has made toward a more sustainable and equitable future for all
2023 Corporate Social Responsibility Report

Learn about the progress we have made to shape a more sustainable and equitable future for all.

Illumina environmental, social, and governance
Environmental, Social, and Governance Hub

Read our Environmental, Social, and Governance policies, download past reports, and review our data.

Explore
Read our latest CSR news

 

2030 Targets

2 billion lives covered

2 billion
covered lives by 2026

100,000 patients supported

Reach > 25,000
medical education learners annually

STEM learners

5 million
STEM learners reached

Gender Represenation

Increase
gender representation in global leadership

Equal Pay Gender icon

Maintain
zero net pay gap

countries reached

Increase
underrepresented minorities in US workforce and leadership

Renewable Electricity

100%
renewable electricity

Net Zero

Net Zero
carbon emissions by 2050
(46% reduction by 2030)

Packaging

75%
reduction in packaging

Most Trusted

100%
strategic suppliers committed to reducing their environmental footprint

Suppliers

20%
spend with diverse suppliers (US)

Suppliers

Achieve
top industry CSR/ESG ratings

See all targets and progress
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.